Zhejiang Medicine Co Ltd Financial Flexibility Index
Zhejiang Medicine Co Ltd financial flexibility index. Zhejiang Medicine Co Ltd (600216) has a Financial Flexibility Index of 0.26x as of September 2025. Free cash flow of CN¥770.79 Million (operating CF CN¥690.77 Million minus capex CN¥80.03 Million) represents 0% of total liabilities (CN¥2.92 Billion). See 600216 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Zhejiang Medicine Co Ltd (1998–2025)
Financial flexibility index of Zhejiang Medicine Co Ltd from 1998 to 2025. Historical Financial Flexibility Index trend for Zhejiang Medicine Co Ltd across 28 annual periods. Check earnings quality score of Zhejiang Medicine Co Ltd to evaluate the quality of earnings relative to operating cash generation.
Zhejiang Medicine Co Ltd Financial Flexibility Index by Year (1998–2025)
Zhejiang Medicine Co Ltd financial flexibility index by year from 1998 to 2025. Year-by-year free cash flow to debt coverage for Zhejiang Medicine Co Ltd. For the full cash flow conversion analysis, see 600216 cash flow metrics.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.78x | CN¥2.33 Billion | CN¥1.89 Billion | CN¥3.00 Billion | ▲ +18.9% |
| 2024 | 0.65x | CN¥1.91 Billion | CN¥1.22 Billion | CN¥2.93 Billion | ▲ +27.5% |
| 2023 | 0.51x | CN¥1.43 Billion | CN¥634.31 Million | CN¥2.79 Billion | ▼ -6.8% |
| 2022 | 0.55x | CN¥1.50 Billion | CN¥520.60 Million | CN¥2.72 Billion | ▼ -11.3% |
| 2021 | 0.62x | CN¥2.08 Billion | CN¥1.14 Billion | CN¥3.35 Billion | ▼ -14.6% |
| 2020 | 0.73x | CN¥1.79 Billion | CN¥1.26 Billion | CN¥2.47 Billion | ▲ +49.9% |
| 2019 | 0.48x | CN¥1.02 Billion | CN¥447.25 Million | CN¥2.11 Billion | ▼ -6.8% |
| 2018 | 0.52x | CN¥1.02 Billion | CN¥579.91 Million | CN¥1.96 Billion | ▼ -2.6% |
| 2017 | 0.53x | CN¥1.07 Billion | CN¥503.47 Million | CN¥2.01 Billion | ▲ +35.3% |
| 2016 | 0.39x | CN¥717.90 Million | CN¥336.14 Million | CN¥1.82 Billion | ▼ -22.6% |
| 2015 | 0.51x | CN¥831.50 Million | CN¥106.54 Million | CN¥1.63 Billion | ▼ -56.8% |
| 2014 | 1.18x | CN¥1.54 Billion | CN¥549.90 Million | CN¥1.31 Billion | ▼ -31.2% |
| 2013 | 1.71x | CN¥1.84 Billion | CN¥655.09 Million | CN¥1.08 Billion | ▼ -15.9% |
| 2012 | 2.04x | CN¥1.75 Billion | CN¥807.49 Million | CN¥860.73 Million | ▲ +29.4% |
| 2011 | 1.57x | CN¥1.26 Billion | CN¥912.75 Million | CN¥798.63 Million | ▼ -16.7% |
| 2010 | 1.89x | CN¥1.46 Billion | CN¥1.32 Billion | CN¥773.86 Million | ▲ +18.9% |
| 2009 | 1.59x | CN¥1.62 Billion | CN¥1.47 Billion | CN¥1.02 Billion | ▲ +73.4% |
| 2008 | 0.92x | CN¥1.33 Billion | CN¥1.20 Billion | CN¥1.45 Billion | ▲ +373.9% |
| 2007 | 0.19x | CN¥381.05 Million | CN¥227.67 Million | CN¥1.97 Billion | ▼ -19.3% |
| 2006 | 0.24x | CN¥419.49 Million | CN¥169.51 Million | CN¥1.75 Billion | ▼ -3.7% |
| 2005 | 0.25x | CN¥367.08 Million | CN¥25.14 Million | CN¥1.48 Billion | ▲ +17.6% |
| 2004 | 0.21x | CN¥252.40 Million | CN¥107.60 Million | CN¥1.19 Billion | ▲ +11.4% |
| 2003 | 0.19x | CN¥197.57 Million | CN¥66.20 Million | CN¥1.04 Billion | ▼ -19.3% |
| 2002 | 0.24x | CN¥236.94 Million | CN¥23.13 Million | CN¥1.01 Billion | ▲ +2.9% |
| 2001 | 0.23x | CN¥218.69 Million | CN¥98.25 Million | CN¥956.66 Million | ▲ +36.5% |
| 2000 | 0.17x | CN¥134.28 Million | CN¥10.58 Million | CN¥801.61 Million | ▲ +419.4% |
| 1999 | 0.03x | CN¥35.32 Million | CN¥-51.90 Million | CN¥1.10 Billion | ▼ -86.3% |
| 1998 | 0.23x | CN¥183.80 Million | CN¥57.72 Million | CN¥782.87 Million | — |